Clinical Trials
5 articles
Life Biosciences Closes $80M to Advance Rejuvenation Therapies
A patient with glaucoma has received the first dose of ER-100, an experimental treatment from Life Biosciences.
Boehringer's obesity drug shows efficacy, faces tolerability challenge
In a pivotal Phase 3 obesity trial, 19% of patients on Boehringer Ingelheim and Zealand Pharma's experimental drug survodutide discontinued treatment due to severe gastrointestinal side effects, a rat
FDA Requests Additional Safety Data for Lilly's Foundayo Obesity Drug
The FDA has requested Eli Lilly conduct additional long-term safety studies for its newly approved oral obesity drug Foundayo, specifically flagging risks like heart attack, stroke, and liver injury.
Revolution Medicines Reports Promising Pancreatic Cancer Drug Results
Patients with previously treated metastatic pancreatic cancer lived an average of 13 additional months with Revolution Medicines' new drug, daraxonrasib, more than double the survival rate of standard
Pfizer Shares Updated Lung Cancer Bispecifics Data at ASCO
At the ASCO Annual Meeting, updated Phase 2 data for Pfizer's bispecific antibody PF-08634404 demonstrated activity as monotherapy in first-line PD-L1-expressing non-small cell lung cancer.